| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60456190c74eef5b9e92a31b5bbc05e9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-25 |
| filingDate |
2002-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b05363df90615e51cf55b63e7097db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbe54469c02ec08708d4b0476364e94b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77897c3ee2a29c82e6e4ccc0df32caf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5c5edbbd98ca610315cf41fb70a3a9c |
| publicationDate |
2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1666881-A2 |
| titleOfInvention |
Diagnostic markers of acute coronary syndromes and methods of use thereof |
| abstract |
The present invention relates to a method of diagnosing myocardial ischemia in a patient, the method comprising: determining a level of N-terminal B-type natriuretic peptide (NT pro-BNP) in a sample obtained from said patient; determining a level of at least two further diagnostic markers in a sample obtained from said patient, wherein one of the at least two further diagnostic markers is an inflammatory marker and the other one of the at least two further diagnostic markers is an ischemic marker, and correlating the level of NT pro-BNP and of said at least two further diagnostic markers to the presence or absence of myocardial ischemia in said patient. The invention also relates to kit for diagnosing myocardial ischemia in a patient and/or for determining a prognosis of a patient diagnosed with acute coronary syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011057249-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011057251-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7341838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501485-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9261517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8221995-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10670611-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7713705-B2 |
| priorityDate |
2001-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |